Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Aug 1;30(7):486-492.
doi: 10.1097/PAI.0000000000001035. Epub 2022 May 20.

Development and Validation of a Digital Analysis Method to Quantify CD3-immunostained T Lymphocytes in Whole Slide Images of Crohn's Disease Biopsies

Affiliations

Development and Validation of a Digital Analysis Method to Quantify CD3-immunostained T Lymphocytes in Whole Slide Images of Crohn's Disease Biopsies

Pavine Lefèvre et al. Appl Immunohistochem Mol Morphol. .

Abstract

The T-lymphocyte-mediated inflammation in Crohn's disease can be assessed by quantifying CD3-positive T-lymphocyte counts in colonic sections. We developed and validated a process to reliably quantify immunohistochemical marker-positive cells in a high-throughput setting using whole slide images (WSIs) of CD3-immunostained colonic and ileal tissue sections. In regions of interest (ROIs) and/or whole tissue sections of 40 WSIs from 36 patients with Crohn's disease, CD3-positive cells were quantified by an expert gastrointestinal pathologist (gold standard) and by image analysis algorithms developed with software from 3 independent vendors. Semiautomated quantification of CD3-positive cell counts estimated in 1 ROI per section were accurate when compared with manual analysis (Pearson correlation coefficient, 0.877 to 0.925). Biological variability was acceptable in digitally determined CD3-positive cell measures between 2 to 5 ROIs annotated on the same tissue section (coefficient of variation <25%). Results from computer-aided analysis of CD3-positive T lymphocytes in a whole tissue section and the average of results from 2 to 5 ROIs per tissue section lacked reliability (overestimation or underestimation and systematic bias), suggesting that absolute quantification of CD3-positive T lymphocytes in a whole tissue section may be more accurate. Semiautomated image analysis in WSIs demonstrated reproducible CD3-positive cell measures across 3 independent algorithms. A computer-aided digital image analysis method was developed and validated to quantify CD3-positive T lymphocytes in colonic and ileal biopsy sections from patients with Crohn's disease. Results support consideration of this digital analysis method for use in future Crohn's disease clinical studies.

PubMed Disclaimer

References

    1. Hammoud L, Adams JR, Loch AJ, et al. Identification of RSK and TTK as modulators of blood vessel morphogenesis using an embryonic stem cell-based vascular differentiation assay. Stem Cell Reports. 2016;7:787–801.
    1. Duan K, Sowamber R, McKee TD, et al. Quantitative assessment of the immune microenvironment in ovarian cancer: a comparison of two digital imaging platforms [abstract 1137]. Lab Investig. 2017;97:283A.
    1. US Food and Drug Administration. 510(k) Substantial equivalence determination decision summary (computer-assisted image analyzer for Ki-67 nuclear protein immunohistochemistry); 2006. Available at: www.accessdata.fda.gov/cdrh_docs/reviews/K053520.pdf . Accessed April 9, 2021.
    1. US Food and Drug Administration. 510(k) Substantial equivalence determination decision summary (computer-assisted image analyzer for immunohistochemistry; Her2/neu protein on formalin-fixed paraffin-embedded breast cancer specimens); 2007. Available at: www.accessdata.fda.gov/cdrh_docs/reviews/K031715.pdf . Accessed April 9, 2021.
    1. Ventana Medical Systems and Roche Diagnostics International. VENTANA PD-L1 (SP142) assay scoring algorithm - urothelial carcinoma. [VENTANA PD-L1 (SP142) Assay Interpretation Guide for Urothelial Carcinoma]; 2020. Available at: https://diagnostics.roche.com/content/dam/diagnostics/us/en/products/v/v... . Accessed April 9, 2021.